A Phase III Trial Assessing the Pharmacodynamic Effect and the Tolerability of Grazax Treatment

Clinical trial NCT00773240 · COMPLETED

Trial details

NCT number: NCT00773240
Sponsor: ALK-Abelló A/S
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Grass Pollen Allergy

Start date: 2008-04-01
Primary completion: 2008-10-01
Enrollment: 276

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.